These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8738174)

  • 1. Regulation of transplacental virus infection by developmental and immunological factors: studies with lactate dehydrogenase-elevating virus.
    Haven TR; Rowland RR; Plagemann PG; Wong GH; Bradley SE; Cafruny WA
    Virus Res; 1996 Apr; 41(2):153-61. PubMed ID: 8738174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
    Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
    Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
    Cafruny WA; Bradley SE
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
    Broen JB; Bradley DS; Powell KM; Cafruny WA
    Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
    Cafruny WA; Bradley SE; Rowland RR
    Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
    Chen Z; Li K; Plagemann PG
    Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
    Monteyne P; Coutelier JP
    J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
    Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
    J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
    Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
    Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.
    Cafruny WA; Chan SP; Harty JT; Yousefi S; Kowalchyk K; McDonald D; Foreman B; Budweg G; Plagemann PG
    Virus Res; 1986 Sep; 5(4):357-75. PubMed ID: 3022497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization.
    Li K; Schuler T; Chen Z; Glass GE; Childs JE; Plagemann PG
    Virus Res; 2000 Apr; 67(2):153-62. PubMed ID: 10867194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine regulation of lactate dehydrogenase-elevating virus: inhibition of viral replication by interferon-gamma.
    Cafruny WA; Bradley SE; Broen JJ; Wong GH
    Antiviral Res; 1994 Apr; 23(3-4):191-201. PubMed ID: 8042859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.
    Chen Z; Li K; Rowland RR; Plagemann PG
    J Neurovirol; 1999 Apr; 5(2):200-8. PubMed ID: 10321985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell.
    Chen Z; Plagemann PG
    J Virol Methods; 1997 May; 65(2):227-36. PubMed ID: 9186946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
    Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
    Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
    Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection.
    Chen Z; Li K; Rowland RR; Anderson GW; Plagemann PG
    J Neurovirol; 1998 Oct; 4(5):560-8. PubMed ID: 9839654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
    Anderson GW; Even C; Rowland RR; Palmer GA; Harty JT; Plagemann PG
    J Neurovirol; 1995 Sep; 1(3-4):244-52. PubMed ID: 9222362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of virus-specific antiserum corresponding to sequences in the lactate dehydrogenase-elevating virus (LDV) ORF6 protein.
    Takahashi-Omoe H; Omoe K; Sakaguchi M; Kameoka Y; Matsushita S; Inada T
    Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):47-55. PubMed ID: 14656541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.